NEW ORLEANS, April 13, 2015 /PRNewswire/ -- MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that Takeda Pharmaceutical Co. is offering $2.2 billion to settle more than 8,000 federal and state lawsuits over its drug Actos. Although the deal is not finalized, it would be a historic class action settlement if and when it is, amounting to about $275,000 per case involved. However, many cases involving more serious injury or death are expected to see settlement values north of $500K. The 8K cases involved in the settlement proposal include 3,500 lawsuits in Lafayette, Louisiana before U.S. District Judge Rebecca Doherty (In Re: Actos (Pioglitazone) Products Liability Litigation, 11-md-02299, U.S. District Court, Western District of Louisiana), and 4,500 suits in California, Illinois, Pennsylvania, and West Virginia. The plaintiffs who have filed suit against Takeda claim that the drug maker hid the cancer risks of the diabetes drug.
The large settlement offering came just after the recent $36.8 million award against Takeda and Lilly for a man who claimed that he developed bladder cancer after taking Actos for about five years (Allen v. Takeda Pharmaceuticals North America Inc., 12-cv-00064, U.S. District Court, Western District of Louisiana (Lafayette)). According to the Bloomberg News report, Takeda's settlement offer is only for patients who have already sued or hired a lawyer to file a suit against Actos' drug maker. Even though the settlement offer doesn't include cases with plaintiffs who have not yet filed a lawsuit claim or hired a lawyer, MTS is advising patients who have developed bladder cancer while taking the diabetes drug Actos to contact them to seek immediate legal guidance to determine if they may beeligible for an award if the settlement is approved. The deal is not yet finalized, however, the time to file a lawsuit claim against Takeda may be running out.
Chris Janish, CEO of MTS, commented on the recent settlement offering, "Without question, any time a drug's possible side effects is a cancer risk, then a jury could award huge amounts of money. It seems that Takeda believes the exposure is too great if the Bloomberg report is accurate and feels a global settlement is best in this serious case. Although the proposed settlement is being done to deter other possible bladder cancer patients who have used Actos from trying to recover funds, our firm believes that the attorneys in our network will still be able to recover money for plaintiffs if they act quickly."
MTS is ready and able to assist those who need lawsuit help with obtaining an Actos law firm or Actos lawyer to provide a free evaluation on their specific case. To learn more about MTS' services involving Actos and other bad drug litigations, please visit: https://www.lawsuitsettlementnews.com/actos-cases
If you already have an attorney and have filed a lawsuit and need a lawsuit funding cash advance or lawsuit money, not to be confused with a lawsuit loan or pre-settlement loan, Lawsuit Settlement News can assist you with these services. Injured parties from Actos usage and/or complications can apply for up to $100K in pre-settlement or settlement lawsuit funding. For a full list of the services that the company provides, visit: https://www.lawsuitsettlementnews.com/about-our-products-and-services
If you, or a loved one, have suffered complications from Actos and need lawsuit money or lawsuit help, including finding an Actos attorney or law firm, call 877.571.0405 to speak with an available agent. You may also fill out a quick application online at: www.lawsuitsettlementnews.com and an agent will contact you shortly.
Disclaimer: MT Services LLC, operator of Lawsuitsettlementnews.com, is not a law firm and cannot provide legal advice on your case; however, MTS works with lawyers involved in mass tort litigations who are willing to provide a free legal consultation at the consumer's request. For a list of full disclosures please visit the company's website disclosure page.
Chris Janish, CEO
SOURCE MT Services LLC